President Donald Trump has nominated Dr. Heidi Overton, a former senior executive at a major pharmaceutical firm, to serve as Commissioner of the Food and Drug Administration. Overton, who spent 15 years at MedPharm Inc., is known for her expertise in drug development and regulatory affairs, but critics point to her close ties to the industry and a lack of experience in public health. Senate confirmation hearings are expected to focus on potential conflicts of interest, her stance on vaccine approvals, and how she would handle the FDA’s response to emerging health threats. Supporters argue her business acumen could streamline the agency’s processes and foster innovation.
On top of everything as it happens